New Model to Detect Common Liver Disease
Posted on: Tuesday, 3 April 2007, 18:00 CDT
U.S. demographic, clinical and laboratory data can be used to detect fibrosis in patients with nonalcoholic fatty liver disease.
This noninvasive method could render liver biopsy unnecessary in a large proportion of patients, according to the findings in Hepatology.
Liver biopsy is the only other way to determine the severity of fibrosis, but it is an expensive and invasive procedure, according to Dr. Paul Angulo of the Mayo Clinic Foundation in Rochester, Minn.
Angulo studied 733 patients diagnosed with NAFLD from 2000 and 2003 who had undergone liver biopsies. Using data from 480 patients, Angulo and colleagues built a statistical model that predicted advanced liver fibrosis in the remaining 253 patients.
NAFLD is the world's most common cause of chronic liver disease.
Source: United Press International
Related Articles
- LifeCycle Pharma Announces Positive Topline Results From Phase II Clinical Study of LCP-Tacro Once Daily in Stable Liver Transplant Patients
- Pufferfish Finding May Help Liver Patients
- China Medical Successfully Completes Development of Liver Fibrosis Diagnostic Reagents
- Albert Einstein Medical Center Enrolls First Patient in the U.S. In Clinical Trial for Artificial Liver Support Device
- Liver Patients Decry UCI
- Liver Patients Were Left in the Dark
- Liver Failure Patients Get Own Stem Cells
- American Liver Foundation Offers Resources and Aid to Liver Patients Affected By Hurricane Katrina
- Journal of Clinical Oncology Publishes Study of Colorectal Liver Metastases Patients Treated With Combination Radiofrequency Ablation and Chemotherapy Suggesting Survival Benefit
- Liver Fibrosis
 |
 |
User Comments (0)
RSS Feeds